Oil Prices Fall on U.S.-Iran Hormuz Deal Hopes 
US 10-Year Treasury Yield at 6% Emerges as New Market Risk Threshold 
Canadian Dollar Faces Pressure as Fed-BoC Policy Gap Widens 
Japan Private-Sector Growth Slows as Domestic Demand Weakens 
OpenAI to Preview GPT-6 Cyber AI Model for Cybersecurity 
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue 
BlackBerry Shares Rise as Q2 Earnings, Revenue Beat Estimates 
BMW 2028 Margin Target Could Fall Below Consensus, UBS Says 
Fed’s Hammack Says Bond Yield Surge Is Not Driven by Inflation Fears 
Select Water Solutions Shares Surge on $700 Million Pilot Water Deal 
Solidigm Eyes $150 Billion IPO as SK Hynix Expands AI Storage Push 
Asian Currencies Mixed as Dollar Holds Near Two-Month High 
Jeff Bezos Invests $32 Billion in Blue Origin as Space Firm Targets Major Growth 
SpaceXAI to Double Nvidia Chips at Colossus 2 by Year-End 
Asian Stocks Fall as Bond Yields Surge Ahead of Trump-Xi Summit 
US Stock Futures Fall as Treasury Yields Surge Ahead of Trump-Xi Summit 
Add as a preferred source on Google
CVS Health Corp., Walmart Inc., and Walgreens Boots Alliance Inc. have all agreed to settle their opioid lawsuit in the United States. It was reported that the three companies have tentatively concurred to pay a collective amount of $13.8 billion.
Their agreement to the settlement is part of their effort to resolve the lawsuits filed against them by thousands of state and local governments. Sources who are familiar with the deal said that CVS Health, Walgreens, and Walmart were all accused of mishandling the sale and distribution of opioid painkillers.
According to Reuters, the proposed settlement will push CVS to pay $5 billion in 10 years, while it will be $5.7 billion for Walgreens to be paid in 15 years, and Walmart will have to shell out $3.1 billion, mostly in advance.
The spokesperson of the group that brought the companies to court was not able to immediately respond to a request for a comment on this latest development in the case. The settlement is said to be the first nationwide deal involving retail pharmacy companies.
Moreover, the settlement is part of the 3,300 lawsuits that have been slapped against the drugmakers since 2017. The plaintiffs also include state and local governments that alleged the drug manufacturers are playing down the risks of their opioid medicines used for pain. They also said that distributors and pharmacies were ignoring red flags as prescriptions were being turned into illegal trafficking.
Walmart, CVS, and Walgreens are three major pharmacies in the U.S., and if the settlement is finalized, it will put an end to the years-long legal battle over opioids. The plaintiffs claimed that the distribution of opioids resulted in a human toll and caused a nuisance to the public, and companies must pay to fix everything.
"Once effectuated, these agreements will be the first resolutions reached with pharmacy chains and will equip communities across the country with the much-needed tools to fight back against this epidemic and bring about tangible, positive change," BBC News quoted the legal team of the plaintiffs as saying in a statement.
Meanwhile, aside from CVS, Walmart, and Walgreens, smaller pharmacy brands such as Kroger Co. and Rite Aid are also said to be facing similar lawsuits, but their cases are still pending.
Photo by Marques Thomas on Unsplash
